Board Meeting27 Oct 2026, 03:30 pm
Ganga Pharmaceuticals Ltd Board Meeting on Nov 2, 2026
AI Summary
Ganga Pharmaceuticals Ltd has announced that its Board of Directors will convene on November 2, 2026. The primary agenda item for this meeting is to consider and approve the Un-audited Financial Results for the half-year period ending September 30, 2026. In line with the company's insider trading policy, the trading window for designated persons has been closed since October 1, 2026, and will reopen 48 hours after the financial results are officially declared to the stock exchange.
Key Highlights
- Board meeting scheduled for November 2, 2026.
- To approve un-audited financial results for H1 FY27.
- Trading window remains closed until results announcement.
- Insider trading policy compliance is being maintained.
Price Impact
More from GANGAPHARM
Management Change26 Sept, 8:40 pm
Ganga Pharmaceuticals Re-appoints Bharat B. Sharma as MD for 3 Years
Insider Trading26 Sept, 7:30 pm
Ganga Pharmaceuticals Closes Trading Window for Un-audited Results
AGM/EGM1 Sept, 8:01 pm
Ganga Pharmaceuticals Sends AGM Letters to Shareholders Without Registered Emails